HOME >> BIOLOGY >> NEWS
Researchers learn certain enzyme inhibitors may help in cancer therapy following initial procedures

DALLAS Sept. 15, 2003 Certain enzyme inhibitors may slow tumor formation within weeks and could lead to treatments that retard or prevent recurrences of cancers, researchers at UT Southwestern Medical Center at Dallas have discovered.

Their findings appear in the current issue of the journal Cancer Research.

The researchers sought to inhibit telomerase, an enzyme that maintains telomeres repeating sequences of DNA at the end of each chromosome that are believed to function as a counting mechanism for cellular aging. Telomerase prevents the shortening of the sequences of DNA that occurs in normal cells as they age. The enzyme is found in most types of tumor cells but not healthy cells, indicating telomerase inhibitors may be a powerful new approach to chemotherapy.

Telomerase inhibition, however, has posed challenges for therapy. In earlier studies, scientists have found that months of treatment with an inhibitor are required before tumor growth could be expected to significantly slow.

The UT Southwestern researchers treated cultured human tumor cells with a unique compound that blocks telomerase activity, and the cell proliferation slowed substantially after just a few weeks.

Further, prostate cancer cells treated with the inhibitor barely formed tumors in mice and yielded very low levels of prostate specific antigen (PSA), a marker associated with malignancy. Cells treated with a similar compound that was not a telomerase inhibitor formed large tumors with high PSA levels.

"Telomerase is widely appreciated as a promising target for therapy," said Dr. David Corey, professor of pharmacology and biochemistry and the study's senior author. "Our results suggest that if you can inhibit telomerase in tumor cells and shorten telomeres, you will slow the growth of tumors."

The researchers also discovered that when the telomerase inhibitor is combined with standard cancer therapeutic agents carboplatin and cisplatin
'"/>

Contact: Scott Maier
scott.maier@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
15-Sep-2003


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 14, 2018 , ... ... management solutions, announced today that Prime Healthcare, a leading operator of over 50 ... requirements. , Persivia’s Bundled Payment solution consists of the industry’s only end ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... MD, founder and medical director of Flatiron Functional Medicine to its Medical Advisory ... Dr. Carnahan will bring to uBiome extensive experience in treating the root causes ...
(Date:11/14/2018)... , ... November 14, 2018 , ... In recognition of ... help raise diabetes awareness and advocacy. The company is reaching out to help educate ... well as emphasize the importance of vision testing for people with the disease. , ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... (PRWEB) , ... November 08, 2018 , ... ... the United States, adopted a machine-learning powered approach to increasing recovery rates by ... around an Artificially Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, ...
(Date:11/7/2018)... ... November 07, 2018 , ... Diversified Technologies, Inc. (DTI) has installed ... Center for Algae Technology and Innovation at ASU. Funded by a USDA NIFA SBIR, ... involved with algal and predator control applications. , Algae ponds get up to 50% ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings ... Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 conference ... history by purchasing tokens and obtaining its first radiology interpretations, one of the ...
(Date:11/3/2018)... ... November 01, 2018 , ... Come to ... Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be ... data reliability. , What should clinical research industry stakeholders keep in mind when ...
Breaking Biology Technology:
Cached News: